Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
September-2021 Volume 24 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
September-2021 Volume 24 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Psoralen inhibits the inflammatory response and mucus production in allergic rhinitis by inhibiting the activator protein 1 pathway and the downstream expression of cystatin‑SN

  • Authors:
    • Wenying Gao
    • Zhenglong Jin
    • Yanxia Zheng
    • Youjia Xu
  • View Affiliations / Copyright

    Affiliations: Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510000, P.R. China, Department of Neurology, Jiangmen Wuyi Hospital of TCM Affiliated Jiangmen TCM Hospital of Ji'nan University, Jiangmen, Guangdong 529000, P.R. China, Department of TCM Pediatrics, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, Guangdong 510000, P.R. China
    Copyright: © Gao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 652
    |
    Published online on: July 14, 2021
       https://doi.org/10.3892/mmr.2021.12291
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Psoralen (PSO) exerts anti‑inflammatory pharmacological effects and plays an important role in a variety of inflammatory diseases. However, the effects of PSO with allergic rhinitis (AR) are yet to be reported. In the present study, an in vitro AR model was generated by inducing JME/CF15 human nasal epithelial cells with IL‑13, after which MTT was used to assess the cytotoxicity of PSO. The expression levels of inflammatory cytokines (granulocyte‑macrophage colony‑stimulating factor and Eotaxin) were determined by ELISA. Furthermore, the expression of inflammatory IL‑6 and ‑8, as well as mucin 5AC, was assessed by reverse transcription‑quantitative PCR and western blotting, and cellular reactive oxygen species were detected using a 2',7'‑dichlorodihydrofluorescein diacetate fluorescent probe. Western blotting was also used to detect the expression and phosphorylation of c‑Fos and c‑Jun in the activator protein 1 (AP‑1) pathway, as well as the expression of cystatin‑SN (CST1). PSO inhibited the inflammatory response and mucus production in IL‑13‑induced JME/CF15 cells. Furthermore, the levels of c‑Fos and c‑Jun phosphorylation in the AP‑1 pathway were decreased in IL‑13‑induced JME/CF15 cells following PSO treatment. The expression of pathway proteins was activated by the addition of PMA, an AP‑1 pathway activator, which concurrently reversed the inhibitory effects of PSO on the inflammatory response and mucus formation. The addition of an AP‑1 inhibitor (SP600125) further inhibited pathway activity, and IL‑13‑induced inflammation and mucus formation was restored. In conclusion, PSO regulates the expression of CST1 by inhibiting the AP‑1 pathway, thus suppressing the IL‑13‑induced inflammatory response and mucus production in nasal mucosal epithelial cells.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Kakli HA and Riley TD: Allergic rhinitis. Prim Care. 43:465–475. 2016. View Article : Google Scholar : PubMed/NCBI

2 

Ri H, Peiyan Z, Jianqi W, Yunteng Z, Gang L and Baoqing S: Desmoglein 3 gene mediates epidermal growth factor/epidermal growth factor receptor signaling pathway involved in inflammatory response and immune function of anaphylactic rhinitis. Biomed Pharmacother. 118:1092142019. View Article : Google Scholar : PubMed/NCBI

3 

Song CH, Bui TT, Piao CH, Shin HS, Shon DH, Han EH, Kim HT and Chai OH: Rosae multiflorae fructus hot water extract inhibits a murine allergic asthma via the suppression of Th2 cytokine production and histamine release from mast cells. J Med Food. 19:853–8539. 2016. View Article : Google Scholar : PubMed/NCBI

4 

Khan DA: Allergic rhinitis and asthma: Epidemiology and common pathophysiology. Allergy Asthma Proc. 35:357–361. 2014. View Article : Google Scholar : PubMed/NCBI

5 

Hoyte FCL and Nelson HS: Recent advances in allergic rhinitis. F1000Res. 7:F1000 Faculty Rev. 13332018. View Article : Google Scholar : PubMed/NCBI

6 

Bernstein DI, Schwartz G and Bernstein JA: Allergic rhinitis: Mechanisms and treatment. Immunol Allergy Clin North Am. 36:261–278. 2016. View Article : Google Scholar : PubMed/NCBI

7 

Seo E, Kang H, Oh YS and Jun HS: Psoralea corylifolia L. Seed extract attenuates diabetic nephropathy by inhibiting renal fibrosis and apoptosis in streptozotocin-induced diabetic mice. Nutrients. 9:8282017. View Article : Google Scholar : PubMed/NCBI

8 

Li X, Yu C, Hu Y, Xia X, Liao Y, Zhang J, Chen H, Lu W, Zhou W and Song Z: New application of psoralen and angelicin on periodontitis with Anti-bacterial, Anti-inflammatory, and osteogenesis effects. Front Cell Infect Microbiol. 8:1782018. View Article : Google Scholar : PubMed/NCBI

9 

Du MY, Duan JX, Zhang CY, Yang HH, Guan XX, Zhong WJ, Liu YZ, Li ZM, Cheng YR, Zhou Y and Guan CX: Psoralen attenuates bleomycin-induced pulmonary fibrosis in mice through inhibiting myofibroblast activation and collagen deposition. Cell Biol Int. Jul 22–2019.doi: 10.1002/cbin.11205 (Epub ahead of print).

10 

Wang C, Al-Ani MK, Sha Y, Chi Q, Dong N, Yang L and Xu K: Psoralen protects chondrocytes, exhibits anti-inflammatory effects on synoviocytes, and attenuates monosodium iodoacetate-induced osteoarthritis. Int J Biol Sci. 15:229–238. 2019. View Article : Google Scholar : PubMed/NCBI

11 

Trop-Steinberg S and Azar Y: AP-1 expression and its clinical relevance in immune disorders and cancer. Am J Med Sci. 353:474–483. 2017. View Article : Google Scholar : PubMed/NCBI

12 

Gazon H, Barbeau B, Mesnard JM and Peloponese JM Jr: Hijacking of the AP-1 signaling pathway during development of ATL. Front Microbiol. 8:26862018. View Article : Google Scholar : PubMed/NCBI

13 

Bejjani F, Evanno E, Zibara K, Piechaczyk M and Jariel-Encontre I: The AP-1 transcriptional complex: Local switch or remote command? Biochim Biophys Acta Rev Cancer. 1872:11–23. 2019. View Article : Google Scholar : PubMed/NCBI

14 

Choi WJ: The heterochromatin-1 phosphorylation contributes to TPA-induced AP-1 expression. Biomol Ther (Seoul). 22:308–313. 2014. View Article : Google Scholar : PubMed/NCBI

15 

Uluçkan Ö, Guinea-Viniegra J, Jimenez M and Wagner EF: Signalling in inflammatory skin disease by AP-1 (Fos/Jun). Clin Exp Rheumatol. 33 (4 Suppl 92):S44–S49. 2015.

16 

Liu X, Yin S, Chen Y, Wu Y, Zheng W, Dong H, Bai Y, Qin Y, Li J, Feng S and Zhao P: LPSinduced proinflammatory cytokine expression in human airway epithelial cells and macrophages via NFκB, STAT3 or AP1 activation. Mol Med Rep. 17:5484–5491. 2018.PubMed/NCBI

17 

Giovannini-Chami L, Marcet B, Moreilhon C, Chevalier B, Illie MI, Lebrigand K, Robbe-Sermesant K, Bourrier T, Michiels JF, Mari B, et al: Distinct epithelial gene expression phenotypes in childhood respiratory allergy. Eur Respir J. 39:1197–1205. 2012. View Article : Google Scholar : PubMed/NCBI

18 

Lei Y, Guo P, An J, Guo C, Lu F and Liu M: Identification of pathogenic genes and upstream regulators in allergic rhinitis. Int J Pediatr Otorhinolaryngol. 115:97–103. 2018. View Article : Google Scholar : PubMed/NCBI

19 

Chai L, Zhou K, Wang S, Zhang H, Fan N, Li J, Tan X, Hu L and Fan X: Psoralen and bakuchiol ameliorate M-CSF plus RANKL-induced osteoclast differentiation and bone resorption via inhibition of AKT and AP-1 pathways in vitro. Cell Physiol Biochem. 48:2123–2133. 2018. View Article : Google Scholar : PubMed/NCBI

20 

Matsukura S, Stellato C, Georas SN, Casolaro V, Plitt JR, Miura K, Kurosawa S, Schindler U and Schleimer R: Interleukin-13 upregulates eotaxin expression in airway epithelial cells by a STAT6-dependent mechanism. Am J Respir Cell Mol Biol. 24:755–761. 2001. View Article : Google Scholar : PubMed/NCBI

21 

Wills-Karp M: Interleukin-13 in asthma pathogenesis. Immunol Rev. 202:175–190. 2004. View Article : Google Scholar : PubMed/NCBI

22 

Chun HW, Kim SJ, Pham TH, Bak Y, Oh J, Ryu HW, Oh SR, Hong JT and Yoon DY: Epimagnolin A inhibits IL-6 production by inhibiting p38/NF-κB and AP-1 signaling pathways in PMA-stimulated THP-1 cells. Environ Toxicol. 34:796–803. 2019. View Article : Google Scholar : PubMed/NCBI

23 

Anuchapreeda S, Rungrojsakul M, Tima S, Chiampanichayakul S and Krig SR: Co-activation of WT1 and AP-1 proteins on WT1 gene promoter to induce WT1 gene expression in K562 cells. Cell Signal. 53:339–347. 2019. View Article : Google Scholar : PubMed/NCBI

24 

Wang L, Lv Q, Song X, Jiang K and Zhang J: ADRB2 suppresses IL-13-induced allergic rhinitis inflammatory cytokine regulated by miR-15a-5p. Hum Cell. 32:306–315. 2019. View Article : Google Scholar : PubMed/NCBI

25 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

26 

Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL and Donaldson DD: Interleukin-13: Central mediator of allergic asthma. Science. 282:2258–2261. 1998. View Article : Google Scholar : PubMed/NCBI

27 

Kuperman DA, Huang X, Koth LL, Chang GH, Dolganov GM, Zhu Z, Elias JA, Sheppard D and Erle DJ: Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat Med. 8:885–889. 2002. View Article : Google Scholar : PubMed/NCBI

28 

Gao Y and Yu Z: MicroRNA16 inhibits interleukin13induced inflammatory cytokine secretion and mucus production in nasal epithelial cells by suppressing the IκB kinase β/nuclear factor-κB pathway. Mol Med Rep. 18:4042–4050. 2018.PubMed/NCBI

29 

Wang B, Gao Y, Zheng G, Ren X, Sun B, Zhu K, Luo H, Wang Z and Xu M: Platycodin D inhibits interleukin-13-induced the expression of inflammatory cytokines and mucus in nasal epithelial cells. Biomed Pharmacother. 84:1108–1112. 2016. View Article : Google Scholar : PubMed/NCBI

30 

Li JP, Xie BP, Zhang WJ, Shi LY, Li WJ, Zeng Y, Gan GX and Li YH: Psoralen inhibits RAW264.7 differentiation into osteoclasts and bone resorption by regulating CD4+T cell differentiation. Zhongguo Zhong Yao Za Zhi. 43:1228–1234. 2018.(In Chinese). PubMed/NCBI

31 

Jin H, Wang L, Xu C, Li B, Luo Q, Wu J, Lv Y, Wang G and Dong J: Effects of Psoraleae fructus and its major component psoralen on Th2 response in allergic asthma. Am J Chin Med. 42:665–678. 2014. View Article : Google Scholar : PubMed/NCBI

32 

Li K, Zhang F, Wei L, Han Z, Liu X, Pan Y, Guo C and Han W: Recombinant human elafin ameliorates chronic hyperoxia-induced lung injury by inhibiting nuclear Factor-Kappa B signaling in neonatal mice. J Interferon Cytokine Res. 40:320–330. 2020. View Article : Google Scholar : PubMed/NCBI

33 

Hu S, Dai J and Chen X: Vitamin D reduces autophagy by regulating NF-κB resistance to Aspergillus fumigatus infection. Gene. 753:1448192020. View Article : Google Scholar : PubMed/NCBI

34 

Xu Q, Xu J, Zhang K, Zhong M, Cao H, Wei R, Jin L and Gao Y: Study on the protective effect and mechanism of Dicliptera chinensis (L.) Juss (Acanthaceae) polysaccharide on immune liver injury induced by LPS. Biomed Pharmacother. 134:1111592021. View Article : Google Scholar : PubMed/NCBI

35 

Jiang D, Li Q, Kolosov VP and Zhou X: The inhibition of aldose reductase on mucus production induced by interleukin-13 in the human bronchial epithelial cells. Int Immunopharmacol. 12:588–593. 2012. View Article : Google Scholar : PubMed/NCBI

36 

Hong Z, Guo Z, Zhang R, Xu J, Dong W, Zhuang G and Deng C: Airborne fine particulate matter induces oxidative stress and inflammation in human nasal epithelial cells. Tohoku J Exp Med. 239:117–125. 2016. View Article : Google Scholar : PubMed/NCBI

37 

Khorasanizadeh M, Eskian M, Gelfand EW and Rezaei N: Mitogen-activated protein kinases as therapeutic targets for asthma. Pharmacol Ther. 174:112–1126. 2017. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Gao W, Jin Z, Zheng Y and Xu Y: Psoralen inhibits the inflammatory response and mucus production in allergic rhinitis by inhibiting the activator protein 1 pathway and the downstream expression of cystatin‑SN. Mol Med Rep 24: 652, 2021.
APA
Gao, W., Jin, Z., Zheng, Y., & Xu, Y. (2021). Psoralen inhibits the inflammatory response and mucus production in allergic rhinitis by inhibiting the activator protein 1 pathway and the downstream expression of cystatin‑SN. Molecular Medicine Reports, 24, 652. https://doi.org/10.3892/mmr.2021.12291
MLA
Gao, W., Jin, Z., Zheng, Y., Xu, Y."Psoralen inhibits the inflammatory response and mucus production in allergic rhinitis by inhibiting the activator protein 1 pathway and the downstream expression of cystatin‑SN". Molecular Medicine Reports 24.3 (2021): 652.
Chicago
Gao, W., Jin, Z., Zheng, Y., Xu, Y."Psoralen inhibits the inflammatory response and mucus production in allergic rhinitis by inhibiting the activator protein 1 pathway and the downstream expression of cystatin‑SN". Molecular Medicine Reports 24, no. 3 (2021): 652. https://doi.org/10.3892/mmr.2021.12291
Copy and paste a formatted citation
x
Spandidos Publications style
Gao W, Jin Z, Zheng Y and Xu Y: Psoralen inhibits the inflammatory response and mucus production in allergic rhinitis by inhibiting the activator protein 1 pathway and the downstream expression of cystatin‑SN. Mol Med Rep 24: 652, 2021.
APA
Gao, W., Jin, Z., Zheng, Y., & Xu, Y. (2021). Psoralen inhibits the inflammatory response and mucus production in allergic rhinitis by inhibiting the activator protein 1 pathway and the downstream expression of cystatin‑SN. Molecular Medicine Reports, 24, 652. https://doi.org/10.3892/mmr.2021.12291
MLA
Gao, W., Jin, Z., Zheng, Y., Xu, Y."Psoralen inhibits the inflammatory response and mucus production in allergic rhinitis by inhibiting the activator protein 1 pathway and the downstream expression of cystatin‑SN". Molecular Medicine Reports 24.3 (2021): 652.
Chicago
Gao, W., Jin, Z., Zheng, Y., Xu, Y."Psoralen inhibits the inflammatory response and mucus production in allergic rhinitis by inhibiting the activator protein 1 pathway and the downstream expression of cystatin‑SN". Molecular Medicine Reports 24, no. 3 (2021): 652. https://doi.org/10.3892/mmr.2021.12291
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team